Yunting Zheng

Yunting Zheng

Auto-generated profile, based on publicly available information

Yunting Zheng

Department of Social Medicine and Health Management, Fujian Medical University, School of Health Management, Fuzhou, Fujian, China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in The Lancet
Verified
Journal Article
Open access
GFGracia Fellmeth
Gracia Fellmeth
KRKelly Rose-Clarke
Kelly Rose-Clarke
CZChenyue Zhao
Chenyue Zhao
LBLaura K Busert
Laura K Busert
YZYunting Zheng
Yunting Zheng
DDDelan Devakumar
Delan Devakumar

24 May 2018 in BMC Public Health
Verified
Journal Article
Open access
PDF file
YZYunting Zheng
Yunting Zheng
Ying JiYing Ji
Ying Ji
HDHongbo Dong
Hongbo Dong
Chun ChangChun Chang
Chun Chang
Previous studies have provided inconsistent findings on smoking among migrants, and very limited data exist on their second-hand smoke exposure. This study aims to investigate internal migrants’ smoking prevalence, second-hand smoke exposure among non-smokers, and knowledge of the health hazards of smoking in 12 major migrant provinces in China in 2013. Data from the 2013 Migrant Dynamics Monitoring Survey in China published by the National Commission of Health and Family Planning was used in this study. Descriptive analysis, Chi-square analysis, and sex-stratified multivariate logistic regression analysis were used to explore the determinants of current smoking and second-hand smoke exposure. Among 7200 migrants, 34.1% (55% male, 4% female) were current smokers. For males, factors associated with current smoking were education year (aOR = 0.95, 95% CI: 0.93–0.98), duration of stay (aOR = 1.01, 95% CI: 1.00–1.03) and occupation (aOR = 1.25, 95% CI: 1.03–1.53). For females, household registration status (aOR = 1.70, 95% CI: 1.04–2.80) was the most important factor associated with current smoking. Sixty five percent of non-smokers were exposed to second-hand smoke. Factors associated with exposure to second-hand smoke were duration of stay (aOR = 1.01, 95% CI: 1.00–1.02), divorced/widowed marital status (aOR = 0.48, 95% CI: 0.25–0.91), occupation (aOR = 1.29, 95% CI: 1.05–1.58) and the nature of employer (aOR = 0.77, 95% CI: 0.60–0.97). About 95% of participants were aware that lung cancer is one of the hazards of smoking. Non-current smokers had a better knowledge of fertility reduction and accelerated aging as hazards of smoking than current smokers (p < 0.01). Knowledge of the impact of smoking on cardiovascular diseases was relatively low compared with knowledge of other smoking-related hazards (26.1–44.3%). Current smoking and exposure to second-hand smoke among internal migrants in China is high. Socio-demographic characteristics and migration status were strongly associated with current smoking and second-hand smoke exposure. We recommend specifically targeted tobacco control interventions to help to address these risk factors, such as focusing on divorced/widowed women.

5 November 2019 in Tobacco Induced Diseases
Verified
Journal Article
Open access
HLHaoxiang Lin
Haoxiang Lin
Chun ChangChun Chang
Chun Chang
ZLzhao liu
zhao liu
YZYunting Zheng
Yunting Zheng
Introduction: Implementing comprehensive smoke-free laws is an important part of tobacco control and has been promoted since China ratified the WHO Framework Convention on Tobacco Control (WHO FCTC) in 2005. This study shows the predictors of adopting subnational smoke-free laws and their...

15 July 2020 in Tobacco Control
Verified
Journal Article
Open access
PDF file
YZYunting Zheng
Yunting Zheng
YWYiqun Wu
Yiqun Wu
MWMengying Wang
Mengying Wang
ZWZijing Wang
Zijing Wang
SWSiyue Wang
Siyue Wang
YHYonghua Hu
Yonghua Hu
Objective To evaluate a comprehensive tobacco control policy package on hospital admissions for acute myocardial infarction (AMI) and stroke in a global city. Design Interrupted time series study. Setting Beijing, China. Population 31 707 AMI and 128 116 stroke hospital admissions recorded by the Beijing Medical Claim Data for Employees in 17.7 million residents from January 2013 to June 2017. Intervention The policy package including all components of MPOWER has been implemented since June 2015. Main outcome measures The immediate change of AMI and stroke hospital admissions and the annual change in the secular trend. Results There was a secular increase trend for the crude hospital admission rates of AMI and stroke during the observational period. After implementation of the policy, immediate reductions were observed in the hospital admissions for both AMI (−5.4%, 95% CI −10.0% to −0.5%) and stroke (−5.6%, 95% CI −7.8% to −3.3%). In addition, the secular increase trend for stroke was slowed down by −15.3% (95% CI −16.7% to −13.9%) annually. Compared with the hypothetical scenario where the policy had not taken place, an estimated 18 137 (26.7%) stroke hospital admissions had been averted during the 25 months of postpolicy period. Conclusions The results indicated significant health benefits on cardiovascular morbidity after the Beijing tobacco control policy package, which highlighted the importance for a comprehensive tobacco control policy at the national level in China. Similar tobacco control policy which consists of all components of MPOWER is urgently needed in other areas, especially in settings with high tobacco consumption, to achieve greater public health gains.

6 January 2020 in Asia & the Pacific Policy Studies
Verified
Journal Article
Open access
PDF file
YZYunting Zheng
Yunting Zheng
YJYing Ji
Ying Ji
Chun ChangChun Chang
Chun Chang
MLMarco Liverani
Marco Liverani
Rural–urban migration is a defining feature of socio‐economic change in contemporary China. It is estimated that internal migrants in China account for 20% of its population of 1.39 billion, providing manpower to the expanding urban industries. Yet internal migrants have long faced barriers to accessing health and other social services in urban destinations, and the migration process may expose them to novel health risks and inequities. Based on the analysis of policy documents and associated material, this article reviews the historical development of health policy in China in relation to internal migrants, identifying elements of continuity and change in the policy agenda and the ways in which migrants have been framed in policy formulations. Against this background, remaining gaps in the current policy framework and implementation challenges are discussed.

2 December 2019 in BMJ Open
Verified
Journal Article
Open access
PDF file
HLHaoxiang Lin
Haoxiang Lin
YLYan Lin
Yan Lin
YZYunting Zheng
Yunting Zheng
ZLzhao liu
zhao liu
Chun ChangChun Chang
Chun Chang
Introduction Providing smoking cessation treatment is an important intervention for tuberculosis (TB) patients. Mobile technologies, such as smartphone applications, have shown promising potential. However, there are few effective applications that could support TB patients in their efforts to quit smoking. To address this problem, we will develop a smartphone application ‘QinTB’ to help TB patients quit smoking, and we will evaluate the clinical efficacy of this application by using a randomised controlled trial (RCT). Methods and analysis This is a two-step study. In the first step, we will develop a smartphone application based on an interactive application of the transtheoretical model and protection motivation theory. Then, we will perform an RCT using a two-arm design; a total of 400 patients will be randomly assigned to the application group or the doctors’ advice group; both treatments will be 6 months and follow-up will be 12 months; the primary outcome is the biochemically verified 6 month sustained abstinence rate; data will be analysed on an intention-to-treat basis. Ethics and dissemination This study was approved by the Ethics Committee of Beijing Research Institute for Tuberculosis Control and Prevention. We will disseminate the findings of this study through peer-reviewed publications and conference presentations. Trial registration number This study was registered in the Chinese Clinical Trial Registry (ChiCTR1900022008) and the stage is Pre-results.